Triple

T7111021
Position Surface form Disambiguated ID Type / Status
Subject Food and Drug Administration Modernization Act of 1997 E165705 entity
Predicate relatedTo P37 FINISHED
Object Food and Drug Administration Safety and Innovation Act E643466 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Food and Drug Administration Safety and Innovation Act | Statement: [Food and Drug Administration Modernization Act of 1997, relatedTo, Food and Drug Administration Safety and Innovation Act]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Food and Drug Administration Safety and Innovation Act
Context triple: [Food and Drug Administration Modernization Act of 1997, relatedTo, Food and Drug Administration Safety and Innovation Act]
  • A. Food and Drug Administration Safety and Innovation Act of 2012 chosen
    The Food and Drug Administration Safety and Innovation Act of 2012 is a U.S. federal law that reauthorized and expanded FDA user fee programs while enhancing the agency’s authority over drug and medical device safety, innovation, and supply chain oversight.
  • B. Food and Drug Administration Amendments Act of 2007
    The Food and Drug Administration Amendments Act of 2007 is a U.S. law that expanded the FDA’s authority over drug and device safety, clinical trials, and post-market surveillance, while enhancing transparency and user fee programs.
  • C. Food and Drug Administration Modernization Act of 1997
    The Food and Drug Administration Modernization Act of 1997 is a U.S. law that overhauled FDA regulatory procedures to speed the approval of drugs and medical devices while enhancing patient access to experimental therapies and modernizing agency operations.
  • D. 21st Century Cures Act
    The 21st Century Cures Act is a U.S. federal law enacted in 2016 that accelerates medical product development and innovation, expands funding for biomedical research and mental health services, and modernizes the regulation of drugs and medical devices.
  • E. Federal Food, Drug, and Cosmetic Act
    The Federal Food, Drug, and Cosmetic Act is a key U.S. law that authorizes the Food and Drug Administration to regulate the safety, labeling, and marketing of food, drugs, medical devices, and cosmetics.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69c6888120f081908f8f01b201dc4a4c completed March 27, 2026, 1:39 p.m.
NER Named-entity recognition batch_69c6e5ecd4488190bf19e42de55da98b completed March 27, 2026, 8:17 p.m.
NED1 Entity disambiguation (via context triple) batch_69c7b8d92fec8190bd275023bdef8e08 completed March 28, 2026, 11:17 a.m.
Created at: March 27, 2026, 2:43 p.m.